Volume 104, Issue 10 pp. 3535-3543
RESEARCH ARTICLE

Development and Characterization of a Biocompatible Soybean Oil-Based Microemulsion for the Delivery of Poorly Water-Soluble Drugs

Carolina Aloisio

Carolina Aloisio

Unidad de Investigación y Desarrollo en Ciencia y Tecnología Farmacéutica (UNITEFA-CONICET), Departamento de Farmacia, Facultad de Ciencias Químicas-Universidad Nacional de Córdoba, Ciudad Universitaria, Córdoba, X5000HUA Argentina

UNESP-Universidade Estadual Paulista, Faculdade de Ciências Farmacêuticas, Araraquara, São Paulo, 14801-902 Brazil

Search for more papers by this author
Marcela R. Longhi

Corresponding Author

Marcela R. Longhi

Unidad de Investigación y Desarrollo en Ciencia y Tecnología Farmacéutica (UNITEFA-CONICET), Departamento de Farmacia, Facultad de Ciencias Químicas-Universidad Nacional de Córdoba, Ciudad Universitaria, Córdoba, X5000HUA Argentina

Telephone: +54-351-5353865; E-mail: [email protected]Search for more papers by this author
Anselmo Gomes De Oliveira

Anselmo Gomes De Oliveira

UNESP-Universidade Estadual Paulista, Faculdade de Ciências Farmacêuticas, Araraquara, São Paulo, 14801-902 Brazil

Search for more papers by this author
First published: 06 July 2015
Citations: 2

Abstract

The aim of this work was the development and characterization of a biocompatible microemulsion (ME) containing soybean oil (O), phosphatidylcholine/sodium oleate/Eumulgin®HRE40 as the surfactant mixture (S) and water or buffer solution as the aqueous phase (W), for oral delivery of the poorly water-soluble drugs sulfamerazine (SMR) and indomethacin (INM). A wide range of combinations to obtain clear oil-in-water (o/w) ME was observed from pseudo-ternary phase diagrams, which was greater after the incorporation of both drugs, suggesting that they acted as stabilizers. Drug partition studies indicated a lower affinity of the drugs for the oil domain when they were ionized and with increased temperature, explained by the fact that both drugs were introduced inside the oil domain, determined by nuclear magnetic resonance. High concentrations of SMR and INM were able to be incorporated (22.0 and 62.3 mg/mL, respectively). The ME obtained presented an average droplet size of 100 nm and a negative surface charge. A significant increase in the release of SMR was observed with the ME with the highest percentage of O, because of the solubilizing properties of the ME. Also, a small retention effect was observed for INM, which may be explained by the differences in the partitioning properties of the drugs. © 2015 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:3535–3543, 2015

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.